Search In this Thesis
   Search In this Thesis  
العنوان
Role of bone marrow scintigraphy in evaluation of patients with malignant lymphomas /
المؤلف
Saleh, Hussein Rabie.
هيئة الاعداد
باحث / Hussein Rabie Saleh
مشرف / Hosna Mohammed Mostafa
مناقش / Amina Mohamed Mustafa
مناقش / Ahsan Jamal al-Din Ghonaimi
الموضوع
Malignant.
تاريخ النشر
2000.
عدد الصفحات
152 p. ;
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
علم الأورام
الناشر
تاريخ الإجازة
26/11/2000
مكان الإجازة
جامعة أسيوط - كلية الطب - Department of Oncology and Nuclear Medicine.
الفهرس
Only 14 pages are availabe for public view

from 167

from 167

Abstract

Toxoplasma gondii is one of the most common pathogenic parasites of humans infecting 30 to 50% of the world population with a worldwide distribution, especially in tropical and sub-tropical zones where humidity is suitable for the organism, Stray cats play an important role in transmission of the disease to humans. The organism IS an obligate intracellular pathogen and most likely is carried via blood stream within infected leukocytes, but dormant cysts have been observed within most tissues ofthe body of infected persons.
The most common and least invasive diagnostic methods for detecting toxoplasmosis are now antibody-based serological tests
The present work concentrated upon the evaluation of different serological commonly used tests used for serodiagnosis of toxoplasmosis in our locality. These tests include:
l-Latex agglutination test (for estimation oftotal Ig antibodies) 2-Indirect haemagglutination test (for detection ofIgG antibodies). 3-ELISA (for detection of both IgG and IgM antibodies).
4- Imrnuno-Comb test (for detection ofboth IgG and IgM antibodies).
The results of the study proved that Latex agglutination test gave the .highest percentage of seropositivity (61.1 %), followed by IgG ELISA test which gave (58.3%), while indirect haemagglutination test gave a positive result of (55.6%). IgM ELISA seropositivity was (52.8%).The immune-comb test gave seropositivity of(52.8%) for IgM antibodies and (55.6%) for IgG antibodies.